Skip to main content
. 2020 Mar 13;104(12):1755–1761. doi: 10.1136/bjophthalmol-2019-315726

Table 1.

Patient demographics at initial treatment

Overall 2010–2012 2011–2013 2012–2014 2013–2015 2014–2016 2015–2017 P value for ANOVA P value for trend test
Number of eyes 2049 136 285 365 551 468 244
Number of patients 1552 105 229 258 405 364 191
Mean age (years)* 63.5±10.8 64.8±10.7 64.0±10.6 63.3±11.1 62.3±11.4 64.6±10.3 63.0±9.5 0.033 0.547
Sex (male/female) 989/563 63/42 139/90 166/92 252/153 247/117 122/69 0.458 0.145
Duration of DM (M)† 94
(36–168)
120
(40–180)
120
(60–192)
71
(24–132)
84
(32–180)
96
(36–168)
60
(24–120)
0.006 0.001
HbA1c (%)* 7.7±1.8 7.5±1.5 7.6±1.8 7.6±1.7 7.9±2.0 7.6±1.6 7.7±1.8 0.170 0.425
eGFR (mL/min/1.73 m2) * 64.8±27.2 65.2±27.6 61.9±23.7 65.9±30.6 67.1±28.2 61.3±25.5 68.1±26.6 0.176 0.657
Cataract surgery n=818
(39.9%)
n=75
(55.1%)
n=96
(33.7%)
n=96
(26.3%)
n=154
(27.9%)
n=114
(24.4%)
n=82
(33.6%)
<0.001 <0.001
Photocoagulation outside the macula n=617
(30.1%)
n=72
(52.9%)
n=114
(40.0%)
n=157
(43.0%)
n=243
(44.1%)
n=159
(34.0%)
n=73
(29.9%)
<0.001 <0.001

*Data are provided as mean±SD.

†Data are provided as median with range.

ANOVA, analysis of variance; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HbA1c, glycohaemoglobin.